ibandronic acid has been researched along with Bisphosphonate Osteonecrosis in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 14 (93.33) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Costela-Ruiz, VJ; García-Martínez, O; Illescas-Montes, R; Manzano-Moreno, FJ; Melguizo-Rodriguez, L; Ramos-Torrecillas, J; Ruiz, C | 1 |
Halling, F; Lux, C; Otto, M; Schlittenbauer, T; Ziebart, T | 1 |
Diz, P; Feijoo, JF; García, A; Limeres, J; López-Cedrún, JL; Peñarrocha, M; Sanromán, JF | 1 |
Acham, S; Jakse, N; Kirnbauer, B; Rugani, P; Truschnegg, A | 1 |
Hagelauer, N; Pabst, AM; Ulbrich, H; Walter, C; Ziebart, T | 1 |
De Luna-Bertos, E; García-Martínez, O; Manzano-Moreno, FJ; Ramos-Torrecillas, J; Ruiz, C | 1 |
Galiti, D; Galitis, E; Karampeazis, A; Labropoulos, S; Migliorati, C; Nicolatou-Galitis, O; Razis, E; Sgouros, J; Tsimpidakis, A | 1 |
Cevreska, L; Jovanovic, R; Karanfilski, O; Pavkovic, M; Petrushevska, G; Stankovic, S; Stojanovic, A | 1 |
Bhattacharyya, I; Bowers, LM; Cohen, DM; Fitzpatrick, SG; Green, JG; Hinkson, DW; Neuman, AN; Stavropoulos, MF | 1 |
Ganesan, K; Russell, J; Shah, K; Yankova, Z | 1 |
Bissinger, O; Ehrenfeld, M; Kolk, A; Mast, G; Mücke, T; Otto, S; Pautke, C; Schreyer, C; Stürzenbaum, SR; Wolff, KD | 1 |
Grätz, KW; Jacobsen, C; Metzler, P; Obwegeser, J; Rössle, M; Zemann, W | 1 |
Diniz-Freitas, M; Diz-Dios, P; Fernández-Feijoo, J; Fernández-Sanromán, J; García-García, A; López-Cedrún, JL | 1 |
Lo, JC; O'Ryan, FS | 1 |
Kraenzlin, CA; Kraenzlin, ME; Lardelli, P; Meier, C; Sieber, P | 1 |
2 review(s) available for ibandronic acid and Bisphosphonate Osteonecrosis
Article | Year |
---|---|
Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review.
Topics: Aged; Antineoplastic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Fatal Outcome; Female; Humans; Ibandronic Acid; Imidazoles; Male; Middle Aged; Neoplasms; Periodontal Diseases; Radiography, Panoramic; Retrospective Studies; Tooth Extraction; Zoledronic Acid | 2015 |
Bisphosphonate-related osteonecrosis of the mandible secondary to postural pressure.
Topics: Aged, 80 and over; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cervical Vertebrae; Clavicle; Diphosphonates; Female; Humans; Ibandronic Acid; Kyphosis; Mandibular Diseases; Posture; Pressure Ulcer | 2012 |
13 other study(ies) available for ibandronic acid and Bisphosphonate Osteonecrosis
Article | Year |
---|---|
Impact of bisphosphonates on the proliferation and gene expression of human fibroblasts.
Topics: Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Cell Differentiation; Cell Proliferation; Diphosphonates; Fibroblasts; Gene Expression Regulation; Humans; Ibandronic Acid; Jaw; Osteoblasts; Real-Time Polymerase Chain Reaction; Zoledronic Acid | 2019 |
Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing.
Topics: Acyclic Monoterpenes; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Endothelial Cells; Humans; Ibandronic Acid; Jaw Diseases; Mouth Diseases; Osteonecrosis; Wound Healing; Zoledronic Acid | 2022 |
Oral bisphosphonate-related osteonecrosis of the jaws in dental implant patients: a case series.
Topics: Administration, Oral; Adrenal Cortex Hormones; Aged; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Dental Implants; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Hypertension; Ibandronic Acid; Male; Mandibular Diseases; Maxillary Diseases; Middle Aged; Retrospective Studies; Risedronic Acid; Risk Factors; Time Factors | 2013 |
Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ).
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Regeneration; Crowns; Debridement; Dental Implantation, Endosseous; Dental Implants; Dental Prosthesis, Implant-Supported; Diphosphonates; Female; Follow-Up Studies; Humans; Ibandronic Acid; Mandible; Mandibular Diseases; Middle Aged; Osseointegration; Tooth Extraction; Tooth Socket | 2015 |
In vitro effects of bisphosphonates on chemotaxis, phagocytosis, and oxidative burst of neutrophil granulocytes.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Chemotaxis; Clodronic Acid; Diphosphonates; Flow Cytometry; Granulocytes; Humans; Ibandronic Acid; Imidazoles; In Vitro Techniques; Neutrophils; Pamidronate; Phagocytosis; Respiratory Burst; Zoledronic Acid | 2015 |
High doses of bisphosphonates reduce osteoblast-like cell proliferation by arresting the cell cycle and inducing apoptosis.
Topics: Alendronate; Apoptosis; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Proliferation; Clodronic Acid; Coloring Agents; Diphosphonates; Dose-Response Relationship, Drug; Flow Cytometry; G1 Phase; Humans; Ibandronic Acid; Necrosis; Osteoblasts; Pamidronate; Resting Phase, Cell Cycle; Spectrophotometry; Tetrazolium Salts; Thiazoles; Time Factors | 2015 |
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphanates.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Male; Middle Aged; Multiple Myeloma; Pamidronate | 2010 |
Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion.
Topics: Aged; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Diphosphonates; Etidronic Acid; Female; Follow-Up Studies; Humans; Ibandronic Acid; Imidazoles; Infusions, Intravenous; Mandibular Diseases; Maxillary Diseases; Middle Aged; Osteoporosis, Postmenopausal; Risedronic Acid; Tooth Extraction; Tooth Socket; Zoledronic Acid | 2012 |
Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.
Topics: Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Male; Maxillary Diseases; Maxillary Sinusitis; Oroantral Fistula; Pamidronate; Radiography, Panoramic; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Zoledronic Acid | 2012 |
Osteopathology induced by bisphosphonates and dental implants: clinical observations.
Topics: Actinomycosis; Administration, Intravenous; Administration, Oral; Alendronate; Anti-Bacterial Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Cone-Beam Computed Tomography; Debridement; Dental Implants; Diphosphonates; Female; Follow-Up Studies; Humans; Ibandronic Acid; Imidazoles; Male; Mandible; Mandibular Neoplasms; Maxilla; Neoplasms; Osteomyelitis; Osteoporosis; Pamidronate; Risk Factors; Time Factors; Zoledronic Acid | 2013 |
Oral bisphosphonate-related osteonecrosis of the jaws: Clinical characteristics of a series of 20 cases in Spain.
Topics: Aged; Aged, 80 and over; Alendronate; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Ibandronic Acid; Male; Middle Aged; Retrospective Studies; Spain | 2012 |
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Antirheumatic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Chronic Disease; Cohort Studies; Debridement; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Ibandronic Acid; Male; Middle Aged; Osteolysis; Osteoporosis; Osteosclerosis; Retrospective Studies; Tooth Extraction; Treatment Outcome; Wound Healing | 2012 |
Intravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.
Topics: Acute-Phase Reaction; Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Drug Administration Schedule; Female; Humans; Ibandronic Acid; Imidazoles; Incidence; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Retrospective Studies; Zoledronic Acid | 2013 |